Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
Maria Prendecki, Candice Clarke, Helena Edwards, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 10, pp. 1322-1329
Open Access | Times Cited: 229

Showing 1-25 of 229 citing articles:

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 397
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 180
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
Rebecca Grainger, Alfred H.J. Kim, Richard Conway, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 191-204
Open Access | Times Cited: 163
Ribosome biogenesis in disease: new players and therapeutic targets
Lijuan Jiao, Yuzhe Liu, Xiyong Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 144
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
Darius F. Ruether, Golda Schaub, Paul Duengelhoef, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 1, pp. 162-172.e9
Open Access | Times Cited: 133
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study
Rachael A. Evans, Sabada Dube, Yi Lu, et al.
The Lancet Regional Health - Europe (2023) Vol. 35, pp. 100747-100747
Open Access | Times Cited: 119
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study
Natacha Madelon, Kim Lauper, Gautier Bréville, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1037-e1045
Open Access | Times Cited: 113
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients
Chris Callaghan, Lisa Mumford, Rebecca Curtis, et al.
Transplantation (2022) Vol. 106, Iss. 3, pp. 436-446
Open Access | Times Cited: 96
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5
Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, et al.
Arthritis & Rheumatology (2022) Vol. 75, Iss. 1
Open Access | Times Cited: 91
Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort
Sakir Ahmed, Pankti Mehta, Aby Paul, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 6, pp. 868-874
Open Access | Times Cited: 74
COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada
Taraneh Bahremand, Jiayun Yao, Christopher Mill, et al.
The Lancet Regional Health - Americas (2023) Vol. 20, pp. 100461-100461
Open Access | Times Cited: 44
Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study
Jennifer K Quint, Sabada Dube, Lucy Carty, et al.
Journal of Infection (2025) Vol. 90, Iss. 3, pp. 106432-106432
Open Access | Times Cited: 2
T cell immunity to SARS-CoV-2
Julia Niessl, Takuya Sekine, Marcus Buggert
Seminars in Immunology (2021) Vol. 55, pp. 101505-101505
Open Access | Times Cited: 74
Rituximab Impairs B Cell Response But Not T Cell Response to COVID‐19 Vaccine in Autoimmune Diseases
Samuel Bitoun, Julien Henry, Delphine Desjardins, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 6, pp. 927-933
Open Access | Times Cited: 69
Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients
Simeon Schietzel, Manuel Anderegg, Andreas Limacher, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e002036-e002036
Open Access | Times Cited: 67
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4
Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 5
Open Access | Times Cited: 63
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 5, pp. 687-694
Open Access | Times Cited: 57
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway
Jie Zhou, Thomas P. Peacock, Jonathan C. Brown, et al.
Cell Reports (2022) Vol. 38, Iss. 6, pp. 110344-110344
Open Access | Times Cited: 57
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
Sabine Haggenburg, Birgit I. Lissenberg‐Witte, Rob van Binnendijk, et al.
Blood Advances (2022) Vol. 6, Iss. 5, pp. 1537-1546
Open Access | Times Cited: 56
Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
Mohammad-Mehdi Mehrabi Nejad, Fatemeh Moosaie, Hojat Dehghanbanadaki, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 55
Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases
C. Sieiro Santos, Sara Calleja Antolín, Clara Moriano Morales, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e001898-e001898
Open Access | Times Cited: 49
Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions
Marco Krasselt, Ulf Wagner, Phuong Nguyen, et al.
Lara D. Veeken (2022) Vol. 61, Iss. SI2, pp. SI180-SI188
Open Access | Times Cited: 49
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry
Jean W. Liew, Milena Gianfrancesco, Carly Harrison, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e002187-e002187
Open Access | Times Cited: 47
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases
Roya Monica Dayam, Jaclyn C. Law, Rogier Goetgebuer, et al.
JCI Insight (2022) Vol. 7, Iss. 11
Open Access | Times Cited: 45
Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients
Tina Thomson, Maria Prendecki, Sarah Gleeson, et al.
EClinicalMedicine (2022) Vol. 53, pp. 101642-101642
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top